comparemela.com

Latest Breaking News On - Sciences corporation - Page 12 : comparemela.com

Canaccord Genuity Group Cuts Exact Sciences (NASDAQ:EXAS) Price Target to $85.00

Canaccord Genuity Group Cuts Exact Sciences (NASDAQ:EXAS) Price Target to $85.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
Sarah-condella
William-blair
Kevint-conroy
Sciences-stock-down
Midwest-professional-planners
Edmond-de-rothschild-holding
Asset-management-co
Canaccord-genuity-group
Mitsubishi-ufj
Vanguard-group-inc
Analyst-recommendations-for-exact-sciences

Citigroup Cuts Exact Sciences (NASDAQ:EXAS) Price Target to $80.00

Citigroup Cuts Exact Sciences (NASDAQ:EXAS) Price Target to $80.00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United-states
William-blair
James-herriott
Kevint-conroy
Securities-exchange-commission
Citigroup
Sciences-corporation
News-ratings-for-exact-sciences-daily
Cullen-frost-bankers-inc
Valley-national-advisers-inc
Sciences-company-profile
Sciences-stock-performance

Canaccord Genuity Group Trims Exact Sciences (NASDAQ:EXAS) Target Price to $85.00

Canaccord Genuity Group Trims Exact Sciences (NASDAQ:EXAS) Target Price to $85.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Kevint-conroy
Sarah-condella
William-blair
Table-wealth-management
Sciences-corporation
Institutional-trading-of-exact-sciences
Canaccord-genuity-group
Citigroup
Cullen-frost-bankers-inc
Valley-national-advisers-inc
Wolff-wiese-magana

Exact Sciences Corp.: The National Institute for Health and Care Excellence (NICE) Recommends Use of Exact Sciences' Oncotype DX Test to Help Guide Chemotherapy Decisions for Node-positive Breast Cancer Patients

Exact Sciences Corp.: The National Institute for Health and Care Excellence (NICE) Recommends Use of Exact Sciences' Oncotype DX Test to Help Guide Chemotherapy Decisions for Node-positive Breast Cancer Patients
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states
Ireland
United-kingdom
American
British
Simon-holt
Caroline-archer
Federico-maiardi
Facebook
Genomic-health-inc
American-society-of-clinical-oncology
Sciences-corporation

Q4 2025 Earnings Estimate for Exact Sciences Co. Issued By Leerink Partnrs (NASDAQ:EXAS)

Q4 2025 Earnings Estimate for Exact Sciences Co. Issued By Leerink Partnrs (NASDAQ:EXAS)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Sarah-condella
Jacoba-orville
Leerink-partnrs
William-blair
Canaccord-genuity-group
News-ratings-for-exact-sciences-daily
Sciences-co
Allspring-global-investments-holdings
Sciences-corporation
Institutional-trading-of-exact-sciences
Vanguard-group-inc

vimarsana © 2020. All Rights Reserved.